Your browser doesn't support javascript.
loading
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks.
Passeron, Thierry; Harris, John E; Pandya, Amit G; Seneschal, Julien; Grimes, Pearl; Kornacki, Deanna; Wang, Mingyue; Ezzedine, Khaled; Rosmarin, David.
Afiliação
  • Passeron T; Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
  • Harris JE; INSERM U1065, C3M, Université Côte d'Azur, Nice, France.
  • Pandya AG; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Seneschal J; Palo Alto Foundation Medical Group, Mountain View, California, USA.
  • Grimes P; University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Kornacki D; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CNRS, UMR-5164, ImmunoConcEpT, Bordeaux, France.
  • Wang M; The Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, USA.
  • Ezzedine K; Incyte Corporation, Wilmington, Delaware, USA.
  • Rosmarin D; Incyte Corporation, Wilmington, Delaware, USA.
J Eur Acad Dermatol Venereol ; 2024 Jul 16.
Article em En | MEDLINE | ID: mdl-39011655
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article